{
  "Q0": "BRCA1/BRCA2 genetic testing",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "No",
  "Q4": "Yes",
  "Q4-Does the patient's clinical presentation match the criteria in those guidelines?": "No",
  "Q4-Which guideline(s) apply?": "NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "No",
  "Q9": "Yes",
  "Q9-Does this patient have a relevant family history or consanguinity that aligns with the policy?": "No",
  "Q10": "No",
  "Q10-If 'No'": "Risk Assessment",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14-Please specify the CPT code": "81162, 81163, 81164, 81165, 81166, 81167, 81212, 81215, 81216, 81217",
  "Q15": "No",
  "Q16": "No",
  "Q17": "According to the policy, the patient would need to meet specific high-risk criteria for BRCA testing. The policy requires completion of an 'Aetna Breast and Ovarian Cancer Susceptibility Gene Testing Prior Authorization Form' along with the Laboratory's Test Requisition Form. Documentation of specific cancer diagnosis in the proband(s) and pertinent medical records may be required. A summary indicating how this testing will change the immediate medical care of the member must also be included with the Prior Authorization request. Genetic counseling should be provided before testing.",
  "match": true
}